Table 2 Differences in the number of samples with specific mutations between the two pathological subtypes
Gene | HGSOC (n = 43) | EEOC (n = 9) | P-value | Effect size |
|---|---|---|---|---|
TP53 | 33 (76.74%) | 6 (66.67%) | 0.6739 | 1.00 |
TTN | 13 (30.23%) | 1 (11.11%) | 0.4147 | 1.00 |
MUC4 | 8 (18.60%) | 1 (11.11%) | > 0.9999 | 1.00 |
OBSCN | 6 (13.95%) | 3 (33.33%) | 0.1767 | 1.00 |
OR1S1 | 7 (16.28%) | 1 (11.11%) | > 0.9999 | 1.00 |
RYR2 | 6 (13.95%) | 1 (11.11%) | > 0.9999 | 1.00 |
ABCC5 | 5 (11.63%) | 1 (11.11%) | > 0.9999 | 1.00 |
MYO18B | 7 (16.28%) | 0 (0.00%) | 0.3309 | 1.00 |
PDE4DIP | 6 (13.95%) | 1 (11.11%) | > 0.9999 | 1.00 |
PKHD1 | 4 (9.30%) | 3 (33.33%) | 0.0900 | 1.00 |
SYNE1 | 4 (9.30%) | 3 (33.33%) | 0.0900 | 1.00 |
ZNF536 | 6 (13.95%) | 0 (0.00%) | 0.5745 | 1.00 |
ZNF831 | 5 (11.63%) | 1 (11.11%) | > 0.9999 | 1.00 |
CRIPAK | 6 (13.95%) | 0 (0.00%) | 0.5745 | 1.00 |
DYNC1H1 | 5 (11.63%) | 1 (11.11%) | > 0.9999 | 1.00 |
KMT2C | 4 (9.30%) | 2 (22.22%) | 0.2750 | 1.00 |
PLXNB2 | 6 (13.95%) | 0 (0.00%) | 0.5745 | 1.00 |
RGS12 | 6 (13.95%) | 0 (0.00%) | 0.5745 | 1.00 |
TAF1L | 4 (9.30%) | 2 (22.22%) | 0.2750 | 1.00 |